Jyong Biotech MENS
NASDAQ MENS
$2.05 +0.02 (+0.99%)
At close: Sep 30, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Notes Payables (2024 - 2025)

Updated

Jyong Biotech's Notes Payables came in at $7.71 million for the quarter ended Dec 31, 2025, up 6.7% from $7.23 million a year earlier.

Analysis

Jyong Biotech (MENS) Notes Payables (2024 - 2025) Analysis & Trends

  • Going back by year, Notes Payables was $7.23 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Jyong Biotech 155.86 Mn 155.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.71 Mn
Jun 30, 2025 22.44 Mn
Dec 31, 2024 7.23 Mn
API Access

Jyong Biotech Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=MENS&period=max&api_key=YOUR_API_KEY